GOS also ameliorated the effects of metabolic syndrome in patients with weight gain, dyslipidaemia, and insulin sensitivity, suggesting that GOS has considerable therapeutic potential for glucose metabolism. This evidence concerns the gene INS and metabolic syndrome.